Rapid Nutrition Announces Operational Enhancements and Product Expansion to Drive Global Growth
Company provides strategic update on manufacturing, innovation, and targeted acquisition plans to support scale and shareholder value
London, United Kingdom – 9 September 2025 - Rapid Nutrition PLC (Euronext Growth: ALRPD), a global HealthTech and wellness company, today announced a series of operational and portfolio enhancements aimed at supporting its long-term growth objectives and further aligning its business model with evolving consumer and investor expectations.
Following the recent introduction of its Creapure®-based creatine product, Rapid Nutrition is now expanding its evidence-based product portfolio with flavour extensions and additional high-protein formats, including convenient on-the-go nutritional snacks. This expansion reflects broader industry trends where health-conscious consumers increasingly seek functional, clinically supported options that fit modern, fast-paced lifestyles.
Notably, this strategic direction echoes emerging industry sentiment. A Bloomberg article published the day after Rapid Nutrition’s initial Creapure® announcement reinforced a similar trend, highlighting growing demand for creatine among women and older adults — particularly for cognitive, bone, and healthy aging benefits. This third-party validation underscores Rapid Nutrition’s forward-thinking approach in addressing evolving consumer needs with science-backed, premium products.
“With demand growing for science-backed, clean-label products, we’re scaling thoughtfully and deliberately,” said Simon St. Ledger, CEO of Rapid Nutrition. “From formulation to fulfilment, we’re building a system that supports innovation, quality, and convenience—key pillars of sustainable consumer health.”
Strengthening Supply Chain Resilience and Quality Assurance
As part of this strategy, Rapid Nutrition will transition a portion of its production back to Australia and the United States, after successfully completing an initial manufacturing run in China earlier this year. This supply chain refinement ensures closer integration between product development, regulatory compliance, and quality control—critical to the company’s direct-to-consumer (DTC) model.
While China continues to represent a strategic growth opportunity, the country's functional foods and healthy snacking sectors are experiencing sustained double-digit market growth, reinforcing its long-term appeal. However, to support its premium, clean-label positioning, Rapid Nutrition believes tight integration between innovation and manufacturing is essential—particularly in light of its focus on vegan-certified, clinically supported ingredients.
This move also mitigates regulatory and operational risks associated with a rapidly evolving compliance environment, especially in emerging markets. It reflects a long-term commitment to transparency, quality, and consumer trust.
Strategic Acquisitions to Complement Organic Growth
In parallel, the company is evaluating selective M&A opportunities as part of a targeted acquisition strategy. This initiative aims to:
- Integrate complimentary wellness brands
- Leverage operational synergies to increase top-line performance
- Foster innovation through cross-brand formulation potential
“This presents a compelling opportunity to combine our premium, evidence-based flagship brands with established channels and complementary products,” added St. Ledger. “It allows us to scale with speed and precision, while staying true to our mission of delivering best-in-class health solutions to a global audience.”
These strategic initiatives collectively support Rapid Nutrition’s long-term vision to become a leading global provider of clean, science-based nutrition solutions. With a foundation built on clinical credibility, operational agility, and global consumer alignment, the company is well-positioned for its next phase of expansion.
About Rapid Nutrition
Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).